{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:27:03Z","timestamp":1792596423614,"version":"4.5.0"},"reference-count":62,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.1001\/jamaoncol.2021.5680","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T12:57:37Z","timestamp":1638449857000},"page":"209","source":"Crossref","is-referenced-by-count":136,"title":["Immune-Mediated Diseases Associated With Cancer Risks"],"prefix":"10.1001","volume":"8","author":[{"given":"Ming-ming","family":"He","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China"},{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Han","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Polychronidis","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany"},{"name":"Study Centre of the German Surgical Society, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Center of Gastrointestinal Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus D.","family":"Knudsen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway"},{"name":"Division of Surgery, Department of Transplantation Medicine, Inflammatory Diseases and Transplantation, Norwegian PSC Research Center, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"coi210082r1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","article-title":"The basis of oncoimmunology.","volume":"164","author":"Palucka","year":"2016","journal-title":"Cell"},{"issue":"37","key":"coi210082r2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3899\/jrheum.091461","article-title":"Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities.","volume":"85","author":"El-Gabalawy","year":"2010","journal-title":"J Rheumatol Suppl"},{"key":"coi210082r3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.07.002","article-title":"Changing epidemiology of immune-mediated inflammatory diseases in immigrants: a systematic review of population-based studies.","volume":"105","author":"Agrawal","year":"2019","journal-title":"J Autoimmun"},{"key":"coi210082r4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113928","article-title":"New insights into the IL-12 and IL-23: from a molecular basis to clinical application in immune-mediated inflammation and cancers.","volume":"175","author":"Chyuan","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"coi210082r5","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2340670","article-title":"The gut microbiota and respiratory diseases: new evidence.","volume":"2020","author":"Chunxi","year":"2020","journal-title":"J Immunol Res"},{"issue":"10218","key":"coi210082r6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.","volume":"395","author":"Ol\u00e9n","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"coi210082r7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/ijc.31835","article-title":"Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults.","volume":"144","author":"McGee","year":"2019","journal-title":"Int J Cancer"},{"issue":"5","key":"coi210082r8","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1053\/j.gastro.2020.07.007","article-title":"Risk of small bowel adenocarcinoma, adenomas, and carcinoids in a nationwide cohort of individuals with celiac disease.","volume":"159","author":"Emilsson","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"coi210082r9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/ecco-jcc\/jjz199","article-title":"Extracolonic cancer risk after total colectomy for inflammatory bowel disease: a population-based cohort study.","volume":"14","author":"Mark-Christensen","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"1","key":"coi210082r10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis.","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"coi210082r11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/rheumatology\/kes350","article-title":"Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.","volume":"52","author":"Mercer","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"coi210082r12","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fmicb.2018.01835","article-title":"The human gut microbiome\u2014a potential controller of wellness and disease.","volume":"9","author":"Kho","year":"2018","journal-title":"Front Microbiol"},{"issue":"6","key":"coi210082r13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrrheum.2017.42","article-title":"Dietary factors in rheumatic autoimmune diseases: a recipe for therapy?","volume":"13","author":"Dahan","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"coi210082r15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/sim.v35.5","article-title":"Statistical methods for studying disease subtype heterogeneity.","volume":"35","author":"Wang","year":"2016","journal-title":"Stat Med"},{"issue":"8","key":"coi210082r16","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3109\/0284186X.2014.1001497","article-title":"Cancer risk and mortality in asthma patients: a Swedish national cohort study.","volume":"54","author":"Liu","year":"2015","journal-title":"Acta Oncol"},{"issue":"4","key":"coi210082r17","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0002-9270(99)00067-2","article-title":"Increased risk of cancer in ulcerative colitis: a population-based cohort study.","volume":"94","author":"Karl\u00e9n","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"coi210082r18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","article-title":"Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study.","volume":"48","author":"Card","year":"2008","journal-title":"J Hepatol"},{"issue":"3","key":"coi210082r19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/carcin\/bgr307","article-title":"Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium.","volume":"33","author":"Rosenberger","year":"2012","journal-title":"Carcinogenesis"},{"issue":"2","key":"coi210082r20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/hep.24743","article-title":"Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New Zealand.","volume":"55","author":"Ngu","year":"2012","journal-title":"Hepatology"},{"issue":"8","key":"coi210082r21","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3109\/10428194.2016.1143938","article-title":"Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?","volume":"57","author":"Elb\u00e6k","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"coi210082r22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/ijd.2019.58.issue-3","article-title":"Incidence of squamous cell carcinoma in oral lichen planus: a 25-year population-based study.","volume":"58","author":"Laniosz","year":"2019","journal-title":"Int J Dermatol"},{"issue":"7423","key":"coi210082r23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth.","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"issue":"9","key":"coi210082r24","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm.2015","article-title":"A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses.","volume":"15","author":"Wu","year":"2009","journal-title":"Nat Med"},{"issue":"7714","key":"coi210082r25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41586-018-0266-0","article-title":"IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.","volume":"559","author":"Calcinotto","year":"2018","journal-title":"Nature"},{"issue":"6380","key":"coi210082r26","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans.","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"issue":"3","key":"coi210082r27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat Microbiol"},{"issue":"1","key":"coi210082r28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/ecco-jcc\/jjx112","article-title":"Long-term risk of cancer following ileal pouch-anal anastomosis for ulcerative colitis.","volume":"12","author":"Mark-Christensen","year":"2018","journal-title":"J Crohns Colitis"},{"issue":"5","key":"coi210082r29","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/2159-8290.CD-20-0304","article-title":"Gut microbiome directs hepatocytes to recruit MDSC and promote cholangiocarcinoma.","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov"},{"issue":"3","key":"coi210082r30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis.","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"issue":"3","key":"coi210082r31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/iid3.2019.7.issue-3","article-title":"Relationship between oral and gut microbiota in elderly people.","volume":"7","author":"Iwauchi","year":"2019","journal-title":"Immun Inflamm Dis"},{"issue":"3","key":"coi210082r32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5387\/fms.2019-21","article-title":"Gut and oral microbiota in autoimmune liver disease.","volume":"65","author":"Abe","year":"2020","journal-title":"Fukushima J Med Sci"},{"issue":"23","key":"coi210082r33","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1158\/0008-5472.CAN-17-1296","article-title":"Oral microbiome composition reflects prospective risk for esophageal cancers.","volume":"77","author":"Peters","year":"2017","journal-title":"Cancer Res"},{"issue":"8","key":"coi210082r34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjx040","article-title":"Cancer risk in the early stages of inflammatory bowel disease in Korean patients: a nationwide population-based study.","volume":"11","author":"Jung","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"2","key":"coi210082r35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cgh.2013.03.034","article-title":"Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.","volume":"12","author":"Kappelman","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"coi210082r36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41564-017-0089-z","article-title":"Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.","volume":"3","author":"Schirmer","year":"2018","journal-title":"Nat Microbiol"},{"issue":"5","key":"coi210082r37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","article-title":"Metabolic biosynthesis pathways identified from fecal microbiome associated with prostate cancer.","volume":"74","author":"Liss","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"coi210082r38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5826\/dpc.0902a07","article-title":"Mucous membrane pemphigoid-associated malignancies: case series and a brief overview of the literature.","volume":"9","author":"La Placa","year":"2019","journal-title":"Dermatol Pract Concept"},{"issue":"1","key":"coi210082r39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/hep.v71.1","article-title":"Regression of idiopathic thrombocytopenic purpura in a patient with eradication of hepatitis C virus by direct-acting antivirals.","volume":"71","author":"Johira","year":"2020","journal-title":"Hepatology"},{"issue":"10","key":"coi210082r41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi\u2019s sarcoma and its associated herpesvirus.","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"coi210082r42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00403-011-1189-x","article-title":"Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin.","volume":"304","author":"Fahl\u00e9n","year":"2012","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"coi210082r43","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.v142.4","article-title":"Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects.","volume":"142","author":"Liu","year":"2018","journal-title":"Int J Cancer"},{"issue":"3","key":"coi210082r44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jamaoncol.2017.4777","article-title":"Association of oral microbiome with risk for incident head and neck squamous cell cancer.","volume":"4","author":"Hayes","year":"2018","journal-title":"JAMA Oncol"},{"issue":"5","key":"coi210082r45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/jnci\/djq564","article-title":"Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease.","volume":"103","author":"Elfstr\u00f6m","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"coi210082r46","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/art.v69.4","article-title":"Rheumatoid arthritis and risk of malignant lymphoma: is the risk still increased?","volume":"69","author":"Hellgren","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"coi210082r47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: incidence, pathogenesis and biology.","volume":"75","author":"Klein","year":"2018","journal-title":"Leuk Res"},{"issue":"3","key":"coi210082r48","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jaci.2019.10.033","article-title":"Allergic disease, corticosteroid use, and risk of Hodgkin lymphoma: a United Kingdom nationwide case-control study.","volume":"145","author":"Rafiq","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"coi210082r49","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"issue":"7","key":"coi210082r50","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/gepi.v43.7","article-title":"Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.","volume":"43","author":"Din","year":"2019","journal-title":"Genet Epidemiol"},{"issue":"10","key":"coi210082r51","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00296-014-2982-6","article-title":"No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan.","volume":"34","author":"Huang","year":"2014","journal-title":"Rheumatol Int"},{"issue":"7","key":"coi210082r52","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/art.v70.7","article-title":"Dysbiotic subgingival microbial communities in periodontally healthy patients with rheumatoid arthritis.","volume":"70","author":"Lopez-Oliva","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"coi210082r53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40168-016-0206-x","article-title":"The lung microbiota in early rheumatoid arthritis and autoimmunity.","volume":"4","author":"Scher","year":"2016","journal-title":"Microbiome"},{"issue":"12","key":"coi210082r54","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1158\/1055-9965.EPI-10-0942","article-title":"Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort.","volume":"19","author":"Brasky","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"coi210082r55","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/annrheumdis-2019-216756","article-title":"Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors.","volume":"79","author":"Wadstr\u00f6m","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"coi210082r56","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13058-020-01343-1","article-title":"Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women.","volume":"22","author":"Cairat","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"2","key":"coi210082r57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2337\/dc14-1996","article-title":"Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation.","volume":"38","author":"Harding","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"coi210082r58","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer.","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"coi210082r59","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy.","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat Med"},{"issue":"6","key":"coi210082r60","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/annrheumdis-2019-216653","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.","volume":"79","author":"Sepriano","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"coi210082r61","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/2012.jama.10857","article-title":"Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis.","volume":"308","author":"Lopez-Olivo","year":"2012","journal-title":"JAMA"},{"key":"coi210082r62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cyto.2016.09.013","article-title":"Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?","volume":"101","author":"Chen","year":"2018","journal-title":"Cytokine"},{"key":"coi210082r40","author":"Sultanova","year":"2017"},{"key":"coi210082r14","unstructured":"UK Biobank. Protocol for a large-scale prospective epidemiological resources. 2010. Accessed June 1, 2020. https:\/\/www.ukbiobank.ac.uk\/wp-content\/uploads\/2011\/11\/UK-Biobank-Protocol.pdf"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2786474\/jamaoncology_he_2021_oi_210082_1644950686.97311.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T11:07:55Z","timestamp":1645096075000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2786474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.5680","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}